Company: IPST
Filing Date: 2025-05-30
Form Type: PRE 14A
Source: 0001788230-25-000100
Chunk: 42

Company: Heritage Distilling Holding Company, Inc.
Filing Date: 2025-05-30
Form: PRE 14A
Chunk 42
---
 proposal will be considered in determining whether the proposal has received the requisite affirmative vote. Brokerage firms do not have discretionary authority to vote shares held in street name on this proposal. If you do not provide your broker with voting instructions, your shares will not be voted on this matter, resulting in a broker non-vote. You may vote “FOR,” “AGAINST,” or “ABSTAIN” on this proposal.

| THE BOARD RECOMMENDS A VOTE  “FOR” THE ELOC SHARE ISSUANCE PROPOSAL |

| HERITAGE DISTILLING HOLDING COMPANY, INC. |     | 27 |     | 2025 Proxy Statement |

#### PROPOSAL FIVE - SPA SHARE ISSUANCE PROPOSAL
Approval, for Purposes of Complying With Nasdaq Listing Rule 5635, of the Issuance of Shares of Common Stock Pursuant Upon Conversion of Series B Preferred Stock and the Exercise of Warrants

### Overview
You are being asked to consider and vote upon a proposal that provides for the potential issuance of shares of common stock in excess of 20% of our outstanding shares of our common stock pursuant to Securities Purchase Agreements dated January 23, 2025 through May 29, 2025 (each, an “SPA”) with certain accredited investors, and the conversion of the shares of our Series B Preferred Stock issued under an SPA and the exercise of the warrants (each a “Warrant”) issued pursuant to an SPA. The information set forth in this SPA Share Issuance Proposal is qualified in its entirety by reference to the full text of the Securities Purchase Agreements, the forms of which are attached as Exhibit ______ to our Current Report on Form 8-K filed with the SEC on ___________, 2025. Stockholders are urged to carefully read these documents.

Between January 23, 2025 and May 29, 2025, we entered into SPAs with 14 accredited investors for the issuance of an aggregate of 742,137 shares of Series B Preferred Stock that are convertible into an aggregate of 15,729,116 shares of common stock at conversion prices between $0.4736 and $1.17 per share and a weighted average conversion price of $0.51. In addition, pursuant to 12 SPAs, we also issued to the purchasers Warrants to purchase an aggregate of 911,225 shares of common stock at an exercise price of $0.01 per share and a negotiated 327,868